Registry Intervention View

Pegcetacoplan

Trial registrations containing the exact intervention label Pegcetacoplan.

Exact registry label · Not reported

4 linked registrations

No aliases or equivalent products have been inferred.

Longevity context

Topics connected by trial metadata

Vision ageing4 trials

Safety context

2 linked registrations report posted results

This is a registry availability fact, not a safety result, comparison, or conclusion.

Understand the safety boundary →

Source records

Registered trials

Active Not RecruitingNCT06161584

A Prospective, Multicenter, Open-Label, Observational Phase 4 Study to Evaluate Real-World Safety, Tolerability, and Treatment Patterns of Pegcetacoplan (Syfovre) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Phase not reported · 300 planned enrolment

Countries listed: 1
Registry update: June 1, 2026

Verify in the registry →

Active Not RecruitingNCT06722157

A Study to Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

PHASE2 · 202 planned enrolment

Countries listed: 1
Registry update: May 14, 2026

Verify in the registry →

CompletedNCT02461771

Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD

PHASE1 · 13 planned enrolment

Countries listed: 2
Registry update: October 6, 2020

Verify in the registry →

TerminatedNCT03465709

Pegcetacoplan (APL-2) in Neovascular AMD

PHASE1 · PHASE2 · 17 planned enrolment

Countries listed: 1
Registry update: September 16, 2020

Verify in the registry →